THC Therapeutics Secures $50M From Shefford Capital Partners To Support Cannabis Acquisitions
Cannabis-focused technology company THC Therapeutics, Inc. (OTCMKTS: THCT) revealed Friday that it has secured up to $50 million in funding from Shefford Capital Partners for acquisitions in the cannabis, alternative therapies and modern health sp
